Interim Findings from MIRAGE Phase III Randomized Trial Sign

/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that interim data from the single center Phase III randomized MIRAGE trial, led by UCLA, comparing...

Related Keywords

United States , San Francisco , California , American , Kishan Amarukishan , Amar Kishan , Prnewswire Viewray Inc , American Society Of Clinical Oncology , Department Of Defense , National Institutes Of Health , International Prostate Symptom Score , Varian Medical Systems Inc , Nasdaq , Genitourinary Oncology Service , American Society For Radiation Oncology , Viewray Inc , Jonsson Comprehensive Cancer Foundation , Prostate Cancer Foundation , Clinical Oncology , Cancers Symposium , Associate Professor , Prostate Cancer , Expanded Prostate , Index Composite , Linac System , National Institutes , American Society , Varian Medical Systems , Guided Radiation Therapy , Viewray , Nc ,